<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00302796</url>
  </required_header>
  <id_info>
    <org_study_id>2005-005500-17</org_study_id>
    <nct_id>NCT00302796</nct_id>
  </id_info>
  <brief_title>Antibiotic Treatment to Patients With Low Back Pain</brief_title>
  <official_title>Antibiotic Treatment to Patients With Low Back Pain Associated With Modic Changes Following Disc Herniation. A Randomized Clinical Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Back Research Center, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Back Research Center, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A large proportion of patients with Low Back Pain (LBP) (80 %) are classified as&#xD;
      &quot;non-specific&quot;, due to the lack of a patho-anatomical diagnosis. This term is not&#xD;
      satisfactory, since it implies uncertainty for both the patient and the clinician. Modic&#xD;
      changes have recently been identified as a pain giving patho-anatomical diagnosis for a&#xD;
      considerable percentage (20-30 %) of LBP patients. The causes of these Modic changes have not&#xD;
      been determined conclusively but bacterial infection is among the plausible causes for those&#xD;
      following a disc herniation.&#xD;
&#xD;
      Purpose The aim of this study is to assess the clinical effect of antibiotic treatment&#xD;
      compared to placebo, in patients with LBP and Modic changes following a lumbar herniated&#xD;
      disc.&#xD;
&#xD;
      Design A double blind prospective clinically controlled trial. Patients will be randomized by&#xD;
      a blinded observer to either Group A: 1 antibiotic tablet 45 patients Group B: 1 placebo&#xD;
      tablet 36 patients Group C: 2 antibiotic tablets 45 patients Group D: 2 placebo tablets 36&#xD;
      patients&#xD;
&#xD;
      The patients will take the drug three times a day for 100 days.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2006</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Low Back Pain Roland Morris Questionaire</measure>
    <time_frame>One year follow-up</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">162</enrollment>
  <condition>Back Pain</condition>
  <arm_group>
    <arm_group_label>Group A, Antibiotic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 antibiotic tablet 45 patients Group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B: 1 placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>1 placebo tablet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C: Antibiotics</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 antibiotic tablets 45 patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group D, Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2 placebo tablets 36 patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bioclavid</intervention_name>
    <description>500 + 125 mg times 3 or 6</description>
    <arm_group_label>Group A, Antibiotic</arm_group_label>
    <arm_group_label>Group C: Antibiotics</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Group B: 1 placebo</arm_group_label>
    <arm_group_label>Group D, Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 18-65 years&#xD;
&#xD;
          -  Previous lumbar herniated disc confirmed by MRI&#xD;
&#xD;
          -  Time since lumbar disc herniation more than 6 months less than 2 years&#xD;
&#xD;
          -  LBP in the area of L1 to L5, with an added Low Back Pain Rating Scale of 6 or more&#xD;
&#xD;
          -  The present MRI shows Modic changes&#xD;
&#xD;
          -  Positive Springing test (SPT) at the level of Modic changes&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergy against antibiotics&#xD;
&#xD;
          -  The Beck Depression Inventory &gt;7,&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Breast feeding&#xD;
&#xD;
          -  All Kidney diseases&#xD;
&#xD;
          -  Pending workers litigation or pension&#xD;
&#xD;
          -  Danish as second language&#xD;
&#xD;
          -  Fertile women who do not user safe anti conseption&#xD;
&#xD;
          -  Reduced liver functions&#xD;
&#xD;
          -  Reduced liver function due to previous treatment wiht amoxicillin/clavulanasid.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hanne B Albert, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Back Research Center, University of Southern Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Back Research Center</name>
      <address>
        <city>Ringe</city>
        <zip>5230</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>July 2009</verification_date>
  <study_first_submitted>March 14, 2006</study_first_submitted>
  <study_first_submitted_qc>March 14, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 15, 2006</study_first_posted>
  <last_update_submitted>May 26, 2010</last_update_submitted>
  <last_update_submitted_qc>May 26, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 27, 2010</last_update_posted>
  <responsible_party>
    <name_title>Hanne Albert</name_title>
    <organization>The Back Research Center</organization>
  </responsible_party>
  <keyword>Low Back Pain,</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

